SCHEMBL1245063

SCHEMBL1245063

Cc1cc(O)c(C(C)C)cc1C(C)(C)C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.55
ALOX15 P16050 6/20 0.49
CYP2C9 P11712 5/20 0.49
CYP2D6 P10635 4/20 0.49
CYP2C19 P33261 4/20 0.49
TP53 P04637 3/20 0.49
ALDH1A1 P00352 8/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
CYP3A4 P08684 3/20 0.44
HIF1A Q16665 3/20 0.44
MAPK1 P28482 2/20 0.44
TSHR P16473 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
TRPA1 O75762 1/20 0.44
CHRM1 P11229 1/20 0.44
SLC6A2 P23975 1/20 0.44
ADRA1A P35348 1/20 0.44
HTR2B P41595 1/20 0.44
CYP1A2 P05177 5/20 0.43
MAPT P10636 5/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Alcohol SCHEMBL9765954 0.93 ALOX15 (0.51) LMNAALOX15CYP2C9CYP2D6CYP2C19
SCHEMBL14981162 0.92 LMNA (0.50) LMNAALOX15CYP2C9CYP2D6CYP2C19
SCHEMBL3013121 0.88 LMNA (0.55) LMNAALOX15CYP2C9CYP2D6CYP2C19
SCHEMBL28152802 0.86 LMNA (0.53) LMNAALOX15CYP2C9CYP2D6CYP2C19
SCHEMBL11865828 0.84 ALOX15 (0.62) LMNAALOX15CYP2C9CYP2D6CYP2C19
SCHEMBL18262815 0.82 LMNA (0.53) LMNAALOX15CYP2C9CYP2D6CYP2C19
SCHEMBL18262858 0.82 ALOX15 (0.44) LMNAALOX15CYP2C9CYP2D6CYP2C19
SCHEMBL18262905 0.82 LMNA (0.49) LMNAALOX15CYP2C9CYP2D6CYP2C19
SCHEMBL8975143 0.82 LMNA (0.49) LMNAALOX15CYP2C9CYP2D6CYP2C19
SCHEMBL18272131 0.82 ALOX15 (0.44) LMNAALOX15CYP2C9CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1467958-B1 PROCESS FOR PREPARING 3,3',5,5',6,6'-HEXAALKYL-2,2'-BIPHENOLS, 3,3',4,4',5,5'-HEXAALKYL-2,2'-BIPHENOLS AND 3,3',4,4',5,5',6,6'-OCTAALKYL-2,2'-BIPHENOLS INVISTA TECH SARL (CH) 2014-01-08 EP disclosed
EP-1467958-B1 PROCESS FOR PREPARING 3,3',5,5',6,6'-HEXAALKYL-2,2'-BIPHENOLS, 3,3',4,4',5,5'-HEXAALKYL-2,2'-BIPHENOLS AND 3,3',4,4',5,5',6,6'-OCTAALKYL-2,2'-BIPHENOLS INVISTA TECH SARL (CH) 2014-01-08 EP disclosed
EP-2279993-A1 Process for preparing 3,3',5,5',6,6'-hexaalkyl-2,2'-biphenols, 3,3',4,4',5,5'-hexaalkyl-2,2'-biphenols and 3,3',4,4',5,5',6,6'-octaalkyl-2,2'-biphenols INVISTA Technologies S.à.r.l. (CH) 2011-02-02 EP disclosed
EP-2279993-A1 Process for preparing 3,3',5,5',6,6'-hexaalkyl-2,2'-biphenols, 3,3',4,4',5,5'-hexaalkyl-2,2'-biphenols and 3,3',4,4',5,5',6,6'-octaalkyl-2,2'-biphenols INVISTA Technologies S.à.r.l. (CH) 2011-02-02 EP disclosed
EP-1586598-B1 Process for preparation of polymeric, phosphorus-containing compositions INVISTA TECH SARL (CH) 2009-09-09 EP disclosed
EP-1571172-B1 Polymeric, phosphorus-containing compositions and their use in hydrocyanation, isomerization and hydroformylation reactions INVISTA TECH SARL (CH) 2008-10-22 EP disclosed
EP-1448503-B1 PROCESS FOR PREPARING 3,3',6,6'-TETRAALKYL-2,2'-BIPHENOLS AND 3,3',6,6'-TETRAALKYL-5,5'-DIHALO-2,2'-BIPHENOLS INVISTA TECH SARL (US) 2008-01-30 EP disclosed
CN-1329358-C Process for the preparation of 3,3 ', 5, 5', 6,6 '-hexaalkyl-2, 2' -biphenols, 3 ', 4, 4', 5,5 '-hexaalkyl-2, 2-biphenols and 3, 3', 4,4 ', 5, 5', 6,6 '-octaalkyl-2, 2' -biphenols PONT CO LTD DU (CH) 2007-08-01 CN disclosed
CN-1982272-A Process for preparing 3,3',5,5',6,6'-hexaalkyl-2,2'-biphenols,3,3',4,4',5,5'-hexaalkyl-2,2'-biphenols and 3,3',4,4',5,5',6,6'-octaalkyl-2,2'-biphenols DU PONT (CH) 2007-06-20 CN disclosed
EP-1586598-A1 Process for preparation of polymeric, phosphorus-containing compositions E.I. du Pont de Nemours and Company (US) 2005-10-19 EP disclosed
WO-2003045883-A1 PROCESS FOR PREPARING 3,3',5,5',6,6'-HEXAALKYL-2,2'-BIPHENOLS, 3,3',4,4',5,5'-HEXAALKYL-2,2'-BIPHENOLS AND 3,3',4,4',5,5',6,6'-OCTAALKYL-2,2'-BIPHENOLS E.I. DU PONT DE NEMOURS AND COMPANY (US) 2003-06-05 WO disclosed
WO-2003045884-A1 PROCESS FOR PREPARING 3,3',6,6'-TETRAALKYL-2,2'-BIPHENOLS AND 3,3',6,6'-TETRAALKYL-5,5'-DIHALO-2,2'-BIPHENOLS E.I. DU PONT DE NEMOURS AND COMPANY (US) 2003-06-05 WO disclosed
US-20030100802-A1 Process for preparing 3,3',5,5',6,6'-hexaalkyl-2,2'-biphenols,3,3',4,4',5,5'-hexaalkyl-2,2'-biphenols and 3,3',4,4',5,5',6,6'-octaalkyl-2,2'-biphenols SHAPIRO RAFAEL (US) 2003-05-29 US disclosed
US-6555718-B1 Oxidatively coupling of phenols in presence of Lewis Acid catalysts E. I. DU PONT DE NEMOURS AND COMPANY 2003-04-29 US disclosed
US-6489517-B1 CHLORINATING DIALKYLPHENOL, OXIDATIVELY COUPLING PRODUCT IN POLAR APROTIC SOLVENT TO PRODUCE DICHLOROTETRAALKYLBIPHENOL, DECHLORINATING TO PRODUCE TETRAALKYLBIPHENOL, BROMINATING OR IODINATING IF DESIRED E. I. DU PONT DE NEMOURS AND COMPANY 2002-12-03 US disclosed
EP-0462121-B1 POLY-ALKYLATED BENZODIOXIN MUSK COMPOSITIONS GIVAUDAN ROURE INT (CH) 1996-03-20 EP disclosed
EP-0462121-A1 POLY-ALKYLATED BENZODIOXIN MUSK COMPOSITIONS. BASF K & F CORP (US) 1991-12-27 EP disclosed
EP-0462121-A4 POLY-ALKYLATED BENZODIOXIN MUSK COMPOSITIONS. BASF K & F CORP (US) 1991-09-30 EP disclosed
WO-1990008533-A1 POLY-ALKYLATED BENZODIOXIN MUSK COMPOSITIONS BASF K & F CORPORATION (US) 1990-08-09 WO disclosed
US-4880775-A PERFUMES BASF K&F CORPORATION (US) 1989-11-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030100802-A1 Process for preparing 3,3',5,5',6,6'-hexaalkyl-2,2'-biphenols,3,3',4,4',5,5'-hexaalkyl-2,2'-biphenols and 3,3',4,4',5,5',6,6'-octaalkyl-2,2'-biphenols CYP4B1, UGT1A4, CYP4X1 LMNA 2946/4885ALOX15 501/4885CYP2C9 71/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.